SCHEMBL3318511

SCHEMBL3318511

O=C(NCc1ccc(Cl)cc1)C12CC3CC(CC(C3)C1)C2

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.75
ALDH1A1 P00352 4/20 0.71
KMT2A Q03164 3/20 0.71
CYP17A1 P05093 2/20 0.71
CYP19A1 P11511 2/20 0.71
MEN1 O00255 2/20 0.71
LMNA P02545 1/20 0.63
GAA P10253 1/20 0.63
MAPT P10636 1/20 0.63
ALOX12 P18054 1/20 0.63
HTT P42858 1/20 0.63
SMN1; SMN2 Q16637 1/20 0.63
NPSR1 Q6W5P4 1/20 0.63
SPHK2 Q9NRA0 2/20 0.62
HSD11B1 P28845 2/20 0.60
SPHK1 Q9NYA1 1/20 0.58
EPHX2 P34913 4/20 0.57
POLB P06746 1/20 0.57
DRD2 P14416 1/20 0.56
DRD4 P21917 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3455848 0.86 HPGD (1.00) HPGDALDH1A1KMT2ACYP17A1CYP19A1
SCHEMBL11739611 0.86 HPGD (0.77) HPGDALDH1A1KMT2ACYP17A1CYP19A1
SCHEMBL3320998 0.84 HPGD (0.75) HPGDALDH1A1KMT2ACYP17A1CYP19A1
SCHEMBL1548224 0.83 CYP17A1 (1.00) HPGDALDH1A1KMT2ACYP17A1CYP19A1
SCHEMBL24713318 0.81 ALDH1A1 (0.68) HPGDALDH1A1KMT2ACYP17A1CYP19A1
SCHEMBL20132767 0.81 ALDH1A1 (0.68) HPGDALDH1A1KMT2ACYP17A1CYP19A1
SCHEMBL11738645 0.81 HPGD (0.69) HPGDALDH1A1KMT2ACYP17A1CYP19A1
SCHEMBL3320032 0.81 KMT2A (0.74) ALDH1A1KMT2AMEN1LMNAGAA
SCHEMBL1548107 0.80 SPHK2 (0.80) HPGDALDH1A1KMT2ACYP17A1CYP19A1
SCHEMBL25190275 0.80 HPGD (0.81) HPGDALDH1A1KMT2ACYP17A1CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100120789-A1 Compound STERIX LIMITED (GB) 2010-05-13 US disclosed
US-20100120789-A1 Compound STERIX LIMITED (GB) 2010-05-13 US disclosed
US-20100120789-A1 Compound STERIX LIMITED (GB) 2010-05-13 US disclosed
US-20090042929-A1 11-Beta-Hydroxysteroid Dehydrogenase Inhibitors STERIX LIMITED (GB) 2009-02-12 US disclosed
US-20090042929-A1 11-Beta-Hydroxysteroid Dehydrogenase Inhibitors STERIX LIMITED (GB) 2009-02-12 US disclosed
US-20090042929-A1 11-Beta-Hydroxysteroid Dehydrogenase Inhibitors STERIX LIMITED (GB) 2009-02-12 US disclosed
EP-1861384-A1 11-BETA-HYDROXYSTEROID DEHYDROGENASE INHIBITORS Sterix Limited (GB) 2007-12-05 EP disclosed
WO-2006100502-A1 11-BETA-HYDROXYSTEROID DEHYDROGENASE INHIBITORS STERIX LIMITED (GB) 2006-09-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042929-A1 11-Beta-Hydroxysteroid Dehydrogenase Inhibitors HSD3B1, HSD3B2, HSD11B1 HPGD 330/4885ALDH1A1 437/4885KMT2A 3083/4885
US-20100120789-A1 Compound NR0B2, NR0B1, NR4A1 HPGD 3581/4885ALDH1A1 3143/4885KMT2A 2533/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.